DK1051491T3 - Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf - Google Patents

Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf

Info

Publication number
DK1051491T3
DK1051491T3 DK99905532.0T DK99905532T DK1051491T3 DK 1051491 T3 DK1051491 T3 DK 1051491T3 DK 99905532 T DK99905532 T DK 99905532T DK 1051491 T3 DK1051491 T3 DK 1051491T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
acid molecules
proteins
epsilon receptor
alpha chain
Prior art date
Application number
DK99905532.0T
Other languages
English (en)
Inventor
Eric R Weber
Catherine A Mccall
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Application granted granted Critical
Publication of DK1051491T3 publication Critical patent/DK1051491T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99905532.0T 1998-01-29 1999-01-28 Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf DK1051491T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/015,734 US6057127A (en) 1998-01-29 1998-01-29 Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
PCT/US1999/001903 WO1999038974A1 (en) 1998-01-29 1999-01-28 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF

Publications (1)

Publication Number Publication Date
DK1051491T3 true DK1051491T3 (da) 2010-08-16

Family

ID=21773286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905532.0T DK1051491T3 (da) 1998-01-29 1999-01-28 Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf

Country Status (10)

Country Link
US (5) US6057127A (da)
EP (1) EP1051491B1 (da)
AT (1) ATE474047T1 (da)
AU (1) AU746218B2 (da)
CA (1) CA2319310C (da)
DE (1) DE69942575D1 (da)
DK (1) DK1051491T3 (da)
ES (1) ES2348971T3 (da)
PT (1) PT1051491E (da)
WO (1) WO1999038974A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
AU7878900A (en) 1999-10-15 2001-04-30 Heska Corporation Method for production and use of mite group 1 proteins
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
WO2002006298A1 (en) * 2000-07-13 2002-01-24 Hyseq, Inc. Soluble immunoglobulin e receptor alpha like molecules
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US6753303B2 (en) * 2001-12-06 2004-06-22 Hershey Entertainment & Resorts Company Whipped cocoa bath
US20070122413A1 (en) * 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists
US8377009B2 (en) * 2007-01-09 2013-02-19 Mystic Pharmaceuticals, Inc. Intranasal cartridge devices
JP5744750B2 (ja) * 2008-12-08 2015-07-08 ヘスティア テック, エル・エル・シーHestia Tec, Llc 多成分材料を形成するためのプロセス及びそのための装置
US10940274B2 (en) * 2015-12-01 2021-03-09 Cipla Limited Nasal spray assembly
EP3192806A1 (en) 2016-01-13 2017-07-19 Affiris AG Alpha chain of the high-affinity ige receptor (fceria)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956752A (en) * 1975-03-12 1976-05-11 Harris Corporation Polarization insensitive lens formed of spiral radiators
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
CA2000878C (en) * 1988-10-18 1999-06-29 Jean-Pierre Kinet Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
JP3457962B2 (ja) * 1991-08-14 2003-10-20 ジェネンテク，インコーポレイテッド 特定Ｆｃεレセプターのための免疫グロブリン変異体
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
FR2697485B1 (fr) * 1992-11-02 1995-01-20 Valeo Vision Feu de signalisation à éléments lumineux modulaires, pour véhicule automobile.
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US5958880A (en) * 1996-12-19 1999-09-28 Heska Corporation Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
US20050170466A1 (en) 2005-08-04
EP1051491B1 (en) 2010-07-14
WO1999038974A1 (en) 1999-08-05
US20030235579A1 (en) 2003-12-25
DE69942575D1 (de) 2010-08-26
US6887672B2 (en) 2005-05-03
EP1051491A1 (en) 2000-11-15
US20070238196A1 (en) 2007-10-11
PT1051491E (pt) 2010-08-20
CA2319310A1 (en) 1999-08-05
ATE474047T1 (de) 2010-07-15
AU2567499A (en) 1999-08-16
AU746218B2 (en) 2002-04-18
US6582701B1 (en) 2003-06-24
ES2348971T3 (es) 2010-12-17
CA2319310C (en) 2011-05-24
US6057127A (en) 2000-05-02
US7226996B2 (en) 2007-06-05

Similar Documents

Publication Publication Date Title
ATE398676T2 (de) Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins
NO20043245L (no) Bindingsproteiner som biosensorer
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
ATE402188T1 (de) Bindungsproteine als biosensoren
NO20064866L (no) IRTA-5 antistoffer og deres anvendelse
NO20082559L (no) Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer
TR199802385T2 (xx) TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler.
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE69808274T2 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
NO20080362L (no) CD19-antistoffer og deres anvendelser
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
NO20043257D0 (no) Innkapslede bindingsproteiner som biosensorer
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
ATE417605T1 (de) Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
DK1465927T3 (da) BAG3-antistoffer til anvendelse til forskning, diagnostik og behandling af sygdomme, der omfatter celledød
MXPA04005992A (es) Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa.
ATE454626T1 (de) Fluoreszenzpolarisationsassay
WO2002102852A3 (en) Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeut ic use
WO2000006733A3 (en) T cell receptor proteins, nucleic acid molecules, and uses thereof